These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24752253)

  • 41. In vitro activity of cefepime against extended spectrum p-lactamase-producing Escherichia coli and Klebsiella pneumoniae from clinical specimens at Bugando Medical Centre, Mwanza, Tanzania.
    Mshana SE; Kidenya BR; Kataraihya JB
    Tanzan J Health Res; 2011 Oct; 13(4):119-21. PubMed ID: 26592057
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum β-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China.
    Bi W; Li B; Song J; Hong Y; Zhang X; Liu H; Lu H; Zhou T; Cao J
    Int J Antimicrob Agents; 2017 Jul; 50(1):29-34. PubMed ID: 28456703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular diversity of Extended-spectrum β-lactamase-producing Escherichia coli from vultures in Canary Islands.
    Carvalho I; Tejedor-Junco MT; González-Martín M; Corbera JA; Suárez-Pérez A; Silva V; Igrejas G; Torres C; Poeta P
    Environ Microbiol Rep; 2020 Oct; 12(5):540-547. PubMed ID: 32755023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases.
    Gibb AP; Crichton M
    Diagn Microbiol Infect Dis; 2000 Dec; 38(4):255-7. PubMed ID: 11146252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
    Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of Clinical Isolates of Extended-Spectrum β-Lactamase-Producing Bacteria with Primer and Probe Sets Developed to Detect bla
    Abe Y; Nakamura K; Kaji D; Takahashi H; Aoki K; Kuse H; Okada H; Ohta K; Ohashi K; Takano Y; Ishii Y; Kanemitsu K
    Jpn J Infect Dis; 2019 Nov; 72(6):381-386. PubMed ID: 31257238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae.
    Bork JT; Heil EL; Leekha S; Fowler RC; Hanson ND; Majumdar A; Johnson JK
    Diagn Microbiol Infect Dis; 2017 Dec; 89(4):328-333. PubMed ID: 29031525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
    Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
    [TBL] [Abstract][Full Text] [Related]  

  • 51. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
    Beceiro A; Maharjan S; Gaulton T; Doumith M; Soares NC; Dhanji H; Warner M; Doyle M; Hickey M; Downie G; Bou G; Livermore DM; Woodford N
    J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and molecular characterization of extended-spectrum β-lactamase (ESBL) and plasmidic AmpC β-lactamase (pAmpC) producing Escherichia coli in dogs.
    Aslantaş Ö; Yilmaz EŞ
    J Vet Med Sci; 2017 Jun; 79(6):1024-1030. PubMed ID: 28450661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae.
    Szabó D; Bonomo RA; Silveira F; Pasculle AW; Baxter C; Linden PK; Hujer AM; Hujer KM; Deeley K; Paterson DL
    J Clin Microbiol; 2005 Oct; 43(10):5058-64. PubMed ID: 16207962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extended-spectrum β-lactamases of Escherichia coli and Klebsiella pneumoniae screened by the VITEK 2 system.
    Espinar MJ; Rocha R; Ribeiro M; Gonçalves Rodrigues A; Pina-Vaz C
    J Med Microbiol; 2011 Jun; 60(Pt 6):756-760. PubMed ID: 21330411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
    Vercauteren E; Descheemaeker P; Ieven M; Sanders CC; Goossens H
    J Clin Microbiol; 1997 Sep; 35(9):2191-7. PubMed ID: 9276386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extended Spectrum β-Lactamase-Producing
    Chenouf NS; Carvalho I; Messaï CR; Ruiz-Ripa L; Mama OM; Titouche Y; Zitouni A; Hakem A; Torres C
    Microb Drug Resist; 2021 Feb; 27(2):268-276. PubMed ID: 32609048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli.
    Livermore DM; Day M; Cleary P; Hopkins KL; Toleman MA; Wareham DW; Wiuff C; Doumith M; Woodford N
    J Antimicrob Chemother; 2019 Feb; 74(2):326-333. PubMed ID: 30388219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High Levels of Resistance to Cephalosporins Associated with the Presence of Extended-Spectrum and AmpC β-Lactamases in
    Lentz SAM; Adam FC; Rivas PM; Souza SN; Cupertino VML; Boff RT; da Motta AS; Wink PL; Barth AL; Martins AF
    Microb Drug Resist; 2020 May; 26(5):531-535. PubMed ID: 31718408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.